TipRanks
Go Ultimate55% OFF

Magle Chemoswed Holding AB (52X) Stock Price & Analysis

52X Stock Chart & Stats

€0.02€0.01(64.29%)
At close: 2:00 AM GMT+2
€0€1€2€325 Oct9 Oct11 Dec16 Jan22 Dec30 Sep
Day’s Range
EUR 0.01 - EUR 0.02
52-Week Range
EUR 0.01 - EUR 1.91
Previous Close
EUR 0.01
Volume
N/A
Average Volume (3M)
9
Market Cap
EUR 3.59M
Enterprise Value
EUR 363.38M
Total Cash (Recent Filing)
EUR 2.08M
Total Debt (Recent Filing)
EUR 343.99M
Price to Earnings (P/E)
―
Beta
0.46
Next Earnings
Feb 24, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Positive TTM revenue growth indicates that customer demand for the company’s development and manufacturing services is still expanding despite current losses. Sustained top-line growth can support operating leverage and provide a broader revenue base from which profitability may recover.

Gross Margin

A gross margin of approximately 54% shows that the company retains meaningful value after direct production and service costs. This provides an underlying economic base for recovery if operating expenses become better aligned with revenue and customer project activity remains healthy.

CDMO And Life Science Positioning

Magle’s combination of pharmaceutical development, analytical work, API activity, and finished-dose manufacturing gives it several ways to serve regulated customers. This breadth can support durable relevance across customer programs while its own drug and medical technology projects add strategic optionality.

Bears Say

Severe Profitability Deterioration

The sharp move into a deeply negative net margin shows that current operating costs are overwhelming gross profit, even with revenue growth and a still-solid gross margin. Unless profitability improves, continued losses could restrict investment capacity and weaken the company’s ability to scale sustainably.

Negative Cash Generation

Operating and free cash flow near negative 110m indicate substantial ongoing cash burn rather than internally funded expansion. Persistent cash outflows can reduce financial flexibility, increase reliance on external funding, and make it harder to absorb execution challenges while investing in customer and proprietary projects.

Higher Leverage And Lower Equity Cushion

Debt now exceeds equity on a TTM basis, while the shrinking equity base reduces the balance-sheet cushion available to absorb further losses. Higher leverage can constrain capital allocation and increase financial risk if negative earnings and cash flow persist over the coming quarters.

Magle Chemoswed Holding AB News

52X FAQ

What was Magle Chemoswed Holding AB’s price range in the past 12 months?
Magle Chemoswed Holding AB lowest stock price was €0.01 and its highest was €1.91 in the past 12 months.
What is Magle Chemoswed Holding AB’s market cap?
Magle Chemoswed Holding AB’s market cap is €3.59M.
When is Magle Chemoswed Holding AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Magle Chemoswed Holding AB’s earnings last quarter?
Magle Chemoswed Holding AB released its earnings results on Aug 12, 2026. The company reported -€0.075 earnings per share for the quarter.
Is Magle Chemoswed Holding AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Magle Chemoswed Holding AB pay dividends?
Magle Chemoswed Holding AB does not currently pay dividends.
What is Magle Chemoswed Holding AB’s EPS estimate?
Magle Chemoswed Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Magle Chemoswed Holding AB have?
Magle Chemoswed Holding AB has 155,117,800 shares outstanding.
What happened to Magle Chemoswed Holding AB’s price movement after its last earnings report?
Magle Chemoswed Holding AB reported an EPS of -€0.075 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Magle Chemoswed Holding AB?
Currently, no hedge funds are holding shares in DE:52X
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology